ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,810Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 46

$1.34M Total Retail Price of All Prescriptions

Rank: 2 out of 46

291 Patients Receiving at Least One Drug in Part D
21%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 291 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 1,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$172 was the average price of a prescription from this provider, compared to $119 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SERTRALINE HCL 367 46 1 2
CLOZAPINE 357 12 2 12
QUETIAPINE FUMARATE 348 45 3 4
OLANZAPINE 344 48 4 7
ABILIFY 329 13 5 14
RISPERIDONE 300 126 6 1
TRAZODONE HCL 256 54 7 3
MIRTAZAPINE 245 48 8 5
BENZTROPINE MESYLATE 238 0 R 9 13
BUPROPION XL 233 29 10 10
FLUOXETINE HCL 220 0 11 8
DIVALPROEX SODIUM 203 44 12 19
VENLAFAXINE HCL ER 199 35 13 9
SEROQUEL 194 52 14 18
TOPIRAMATE 188 0 15 30
BUSPIRONE HCL 182 25 16 20
DIVALPROEX SODIUM ER 173 0 17 22
LAMOTRIGINE 167 13 18 15
ZIPRASIDONE HCL 151 0 19 26
CYMBALTA 133 0 20 11
RISPERDAL CONSTA 126 23 21 28
GABAPENTIN 115 26 22 31
CITALOPRAM HBR 115 17 22 6
ZYPREXA 115 18 22 29
INVEGA 112 0 25 36
LITHIUM CARBONATE 109 0 26 23
BUPROPION HCL SR 103 30 27 32
ZOLPIDEM TARTRATE 100 15 28 17
PAROXETINE HCL 93 25 29 21
DOXEPIN HCL 89 0 30 49
HYDROXYZINE PAMOATE 88 11 R 31 33
FLUVOXAMINE MALEATE 78 39 32 39
ESCITALOPRAM OXALATE 78 14 32 16
NAMENDA 76 42 34 24
AMITRIPTYLINE HCL 73 0 R 35 44
LUNESTA 72 0 36 53
OLANZAPINE ODT 71 0 37 46
INVEGA SUSTENNA 69 0 38 37
PROPRANOLOL HCL 62 0 39 38
PRAZOSIN HCL 60 0 40 57
OXCARBAZEPINE 59 0 41 35
ROPINIROLE HCL 50 0 42 61
HALOPERIDOL 50 0 42 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.